Found: 1
Select item for more details and to access through your institution.
FDA Drug Approval Summary: Pegaspargase (Oncaspar) for the First-Line Treatment of Children with Acute Lymphoblastic Leukemia (ALL).
- Published in:
- Oncologist, 2007, v. 12, n. 8, p. 991, doi. 10.1634/theoncologist.12-8-991
- By:
- Publication type:
- Article